The dictates of the in vitro diagnostic regulation (IVDR) and “bureaucratic” issues are dampening the industry’s innovation ...

The market is projected to expand at a compound annual growth rate of 6% from 2024 to 2034. Growing clinical evidence is ...

Siemens has announced plans to ‘deconsolidate’ its remaining stake in Siemens Healthineers by transferring 30% of shares to ...

Biogen has completed the acquisition of Alcyone Therapeutics, for $85m upfront payment, to boost central nervous system (CNS) ...

Zimmer Biomet has received 510(k) clearance from the US Food and Drug Administration (FDA) for ROSA Knee with OptimiZe ...